Nav1.7 selective blockers and their current status of development

1,375 views

|

November 13, 2018

  • Share
  • Dr Zahid Ali, Mundipharma Research and Development, explains selective Nav1.7 blockers and why they are important for analgesic research. He also outlines their current status of development.

    Drug Discovery

    Keep up to date with all your favourite videos and channels.

    Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.